Scientific Advisory Board
Hugh O’Brodovich, MD, FRCP(C), is the Arline and Pete Harman Professor of Pediatrics (Emeritus) at the Stanford School of Medicine where he previously held the positions of Chair of the Department of Pediatrics, Adalyn Jay Physician in Chief at Lucile Packard Children’s Hospital Stanford and Director of the Stanford Child Health Research Institute. Prior to his move to Stanford he had held the positions of Division Chief of Respiratory Medicine and Chair of Paediatrics at the University of Toronto and the Paediatrician in Chief at Toronto’s Hospital for Sick Children (SickKids). Dr. O’Brodovich has been the Chair of the Pediatric Pulmonology Sub-Board of the American Board of Pediatrics, an Associate Editor of the American Review of Respiratory Disease, Editor of Pediatric Research, member of the editorial board of the American Journal of Physiology, President of the Fleischner Society and has served on the Council of the American Pediatric Society and boards of other academic organizations. He has published 174 peer reviewed manuscripts and 21 book chapters and until his retirement in July, 2016 he maintained an active research program and clinical practice. He has been elected as a Fellow of the Canadian Academy of Health Sciences and of the American Association for the Advancement of Science. Dr. O’Brodovich currently serves as a member of the Board of Directors of Ontario’s Central West Local Health Integration Network.
Prof. Dr. Andrew R. Colin, MD, serves as a Professor of Pediatrics. Prof. Dr. Colin serves as Director of the Division of Pediatric Pulmonology at Miller School of Medicine, University of Miami. He served as Associate-Chief of a Technion-affiliated Department of Pediatrics in Haifa, Israel. In 1990 he joined the Faculty of Children`s Hospital Boston at Harvard Medical School. He served as Clinical Director of the Division of Respiratory Diseases and also served as Associate Professor at Harvard Medical School. He also served at Children`s Hospital, Boston. He serves as a Member of Medical Advisory Board of EarlySense Ltd. He serves as Member of Scientific Advisory Board at AIT Therapeutics, Inc. His expertise includes: asthma, cystic fibrosis, structural and functional development of the respiratory system and related problems including lung diseases of prematurity, pediatric bronchoscopy and more. He participated in research and teaching and received the Klaus Peter International Teaching Award of Harvard Medical School and was the first recipient of the Andrew A. Colin Teaching Award. He is certified by the American Board of Pediatrics in Pediatrics and Pediatric Pulmonology. He has participated in over 20 studies in his field including ones sponsored by the NIH, Genentech, GlaxoSmithKline and the Cystic Fibrosis Foundation’s Therapeutic Development Network. He has authored or co-authored over 80 peer-reviewed publications, as well as multiple reviews. He received his MD at Technion – Israel Institute of Technology and completed his pediatric training in hospitals related to that medical school. He trained in Pediatric Pulmonology and Pediatric Intensive Care at Hadassah Hospital in Jerusalem and subsequently at Children`s Hospital Boston, Harvard Medical School.
John P. Clancy, MD, has served in several leadership roles at Univeristy of Alabama, Cincinnati Children’s and within the international cystic fibrosis (CF) community. Some of his leadership roles include membership on the CFF Clinical Research Committee (2003 to present), the CFF-TDN Steering Committee (2002 to 2007), the CFF-TDN Translational Research Center Committee (2008 to present), DSMB membership for the Rare Lung Disease Consortium within the NIH Rare Disease Research Network (2005 to 2009, Chairman from 2010 to present); organizing committee membership for the North American CF Conference (2003 to present) and the European CF Society (2010), co-chair of the CFFT Biomarkers Consortium (2010 to present), member of the Promotion and Tenure Committee for the UAB Department of Pediatrics (2003 to 2010) and the UAB SOM (2007 to 2010, including committee chair). Dr. Clancy has been the primary or co-mentor of more than 20 fellows, graduate students and junior faculty. He has been the initial recipient of two endowed chairs, including the Raymond K. Lyrene Chair in Pediatric Pulmonary Medicine at the University of Alabama (2005), and the Tom Boat Chair in Cystic Fibrosis Clinical and Translational Research at Cincinnati Children’s (2011).
Dr. Richard Malley, also known as Rick, MD serves as an Assistant Professor of Pediatrics of Children’s Hospital Boston. Dr. Malley is an Expert in infectious diseases in children and an experienced Pneumococcal Researcher at Harvard Medical School. He is Affinivax scientific founder and Chairman in Pediatric Infectious Diseases, Boston Children’s Hospital at Kenneth McIntosh. He is an experienced physician with more than 20 years of experience treating infectious diseases, Dr. Malley has led an international effort in the development of novel vaccines in collaboration with colleagues and global nonprofit health organizations such as PATH and the Bill and Melinda Gates Foundation. He serves as a Member of Scientific Advisory Board at Arsanis Inc. He serves as a Director of the Travel and Geographic Medicine Clinic at Boston Children’s Hospital. He serves as a Director of Affinivax, Inc. Dr. Malley serves as a Member of Scientific Advisory Board of Genocea Biosciences, Inc. and AIT Therapeutics, Inc. Dr. Malley runs a research laboratory at Children’s Hospital Boston, with funding from NIH and PATH, as well as from the Pamela and Jack Egan Fund. He has initiated a collaboration with Instituto Butantan in Brazil for the manufacture of a pneumococcal vaccine for use in developing countries. He has published over forty peer-reviewed research articles in the field of infectious diseases and vaccines. Dr. Malley authored and co-authored 80 scientific publications in the field of infectious diseases.
Prof. Dr. Asher Tal, MD, serves as Head of the Pediatrics B Department and of the Sleep Lab of the Soroka Medical Center, Beer Sheva. Prof. Dr. Tal serves as Vice President of Clinical Development at AIT Therapeutics, Inc. He serves as the Chief Physician for the Millenium Sleep Laboratory. Since 2000, he has been Professor of Pediatrics at the Ben- Gurion University. He has been Head of Department of Pediatrics B at the Soroka Medical Center, in Beer-Sheva, Israel since 1992. He joined the Soroka Medical Center in 1984 and held senior positions such as Senior Physician, Head of Pediatric Pulmonary Unit, Medical Director of Pediatric Sleep. He serves as the Chairman of The Scientific Advisory Board of Advanced Inhalation Technology Ltd. He served as Chairman of the Division of Pediatrics in the Faculty of Health Sciences at Ben-Gurion University in Beer Sheva. He serves as a Member of Board of Advisor at Discover Medical Devices Ltd. He has been a Director of Oridion Systems Ltd since February 2011. He served as a Member of Scientific Advisory Board for WideMed Ltd., and AIT Therapeutics, Inc. He is the author of several refereed articles in scientific journals. He is the author and coauthor of more than 100 publications and is a member of the Editorial board of the journal “Pediatric Pulmonology”. Since 2008, Prof. Prof. Dr. Tal is the Chair of the Israeli Association of Pediatric Pulmonology. Prof. Tal received MD Degree from Technion Medical School, Haifa, Israel in 1975, Pediatric Residency from Soroka Medical Center, Beer-Sheva from 1976 to 1982, Pediatric Pulmonology Research Fellowship (Basic Science), from Hadasa University Hospital, Jerusalem ( Prof. S. Godfrey) in 1980, 3 Pediatric Pulmonology Fellowship, Children’s Hospital, Health Sciences Centre from University of Manitoba, Winnipeg, Canada in 1982, Pediatric flexible bronchoscopy, post- graduate course, Davos, Switzerland in 1991 and Advance Trauma Life Support (ATLS), Military course in 1994.
Prof. Dr. Hannah Blau, MD, serves as Member of Scientific Advisory Board at AIT Therapeutics, Inc. Prof. Dr. Blau is the Director of the Pulmonology Institute and the Kathy and Lee Graub Cystic Fibrosis Center at Schneider Children’s Medical Center of Israel. Her fields of research include CF, asthma, lung cell biology and inflammation. In particular, recent work has focused on induced sputum in the very young for early markers of inflammation and infection; emerging infections in CF, spectrum of CF phenotypes, preschool pulmonary function testing. She is a founding member (now Secretary) of the Israeli Society for Cystic Fibrosis and was a founding member of the Israel Society for Pediatric Pulmonology. She is a member of the International Pediatric Pulmonary Network of the American Thoracic Society, has been on the Program Committee for the ATS conference through the Pediatric Assembly and is a member of the Pediatric Infection and Immunology Committee of the European Respiratory Society Pediatric Assembly. The Graub CF Centre, which she heads, is part of the Clinical Trials Network (CTN) of the European CF Society (ECFS). She is a member of the Newborn Screening Working Group of the European Cystic Fibrosis Society as well as the author of the Standards of Practice for Sputum Induction as part of the ECFS. She is a reviewer for eight international medical journals and is an author or co-author of 85 peer-reviewed manuscripts.
Professor Greenberg has almost 20 years of professional experience in the research and treatment of infectious diseases. Since 2005, he has served as a professor of pediatrics and infectious diseases and the principal consultant to the Infectious Disease Clinical Service (pediatric oncology), Chairman of the Division of Pediatrics at Soroka Medical Center in Beer-Sheba, Israel. In June 2014, he was appointed director of Pediatric Infectious Disease Unit at Soroka University Medical Center. In addition, he was a member of the WHO’s Pneumonia Vaccine Trial Investigators’ Group and is a board member of the Educational Committee of the European Society of Pediatric Infectious Diseases. Prof. Greenberg is board certified in pediatrics and has obtained his MD from Ben-Gurion University of the Negev. He completed a fellowship in 1999 in pediatric infectious diseases at British Columbia Children’s Hospital in Vancouver, British Columbia, Canada.
Professor Yossef Av-Gay, PhD, co-founded AIT Ltd. in 2011 and became a director of AIT Ltd. at that time. Prof. Av-Gay became AIT Ltd’s Chief Scientific Officer in 2012, and was AIT Ltd’s Chairman from January 2014 until July 2015. He has been a professor of microbiology at the UBC, Faculty of Medicine and the Division of Infectio and is a member of the scientific review panels of the Canadian Institute of Health Research (since 2010), the French Agence Nationale de la Rechereche (since 2008), Innovative Medicine Innovations, the U.S. Natius Diseases since 1997. He is engaged in basic research in microbial genetics and biochemistry of microorganisms, and his research focuses on translational research of bacterial pathogens aiming at antimicrobial drug development. He is a consultant to several pharmaceutical and biotechnology companies,onal Institutes of Health (since 2010), the European Commission FP6, FP7 (since 2002) and Horizon 2020 (since 2014). Dr. Av-Gay received a B.Sc. in biology, a M.Sc. in microbiology and a Ph.D. in molecular microbiology from Tel Aviv University.